- Microdosing refers to the practice of regularly using small amounts of psychedelic substances that do not impair cognitive function.
- Evidence from mostly small observational studies suggests that microdosing psilocybin, the psychoactive ingredient in magic mushrooms, can improve cognitive function and alleviate symptoms of depression and anxiety.
- In agreement with these data, a large study now shows that individuals who microdose psilocybin showed improved mood and a greater decline in anxiety, depression, and stress over a one-month period than those who did not microdose.
- Notably, these improvements in mental health and mood associated with microdosing psilocybin were also observed in individuals with mental health concerns.
“We found psilocybin microdosing to be associated with improvements in mood and mental health, which adds to the growing body of research that suggests positive benefits of microdosing specifically in the domains of mental health and cognition.” — Joseph Rootman, study co-author“We hope that our findings will help facilitate the development of more rigorously designed clinical trials,” he added. shownTrusted Source promise in the treatment of individuals with depression, anxiety, and substance use disorders. These studies have generally used regular doses of psilocybin that produce euphoric and hallucinogenic effects. However, the use of regular doses of psilocybin can also produce unpleasant and terrifying experiences, also referred to as “bad trips”. This has led to the adoption of a practice called microdosing,Trusted Source which involves the consumption of small amounts of psychedelic substances that do not produce hallucinogenic effects. Most ‘microdosers’ use about 10% of the regular dose of psilocybin, equivalent to about 100-300 milligrams of dried mushrooms, between 2-5 times a week.
Source: Microdoses of psychedelic mushrooms may improve mood and mental health